1 - 10 of 419 Results
Condition Status ˆ Requirements ˇ Location Near You ˇ
Hepatitis B
Active, not recruiting
15+

To find a center near you, please provide a Country or Postal Code.

NUC 30956-A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B alone
NUC 30956-A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B alone
Human Immunodeficiency Virus (HIV)
Recruiting
18+

To find a center near you, please provide a Country or Postal Code.

208983-Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany
208983-Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

209035-Phase 2b, open-label, multicenter, rollover study to assess antiviral activity and safety of Long-acting Cabotegravir (CAB LA) plus Long-acting Rilpivirine (RPV LA), administered every 2 months (Q2M), in human immunodeficiency virus (HIV)- positive subjects from the LATTE study
209035-Phase 2b, open-label, multicenter, rollover study to assess antiviral activity and safety of Long-acting Cabotegravir (CAB LA) plus Long-acting Rilpivirine (RPV LA), administered every 2 months (Q2M), in human immunodeficiency virus (HIV)- positive subjects from the LATTE study
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

205543-An efficacy, safety, and tolerability study comparing dolutegravir (DTG) plus lamivudine (3TC) with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 2)
205543-An efficacy, safety, and tolerability study comparing dolutegravir (DTG) plus lamivudine (3TC) with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 2)
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

205888-Attachment Inhibitor comparison in Heavily Treatment Experienced patients
205888-Attachment Inhibitor comparison in Heavily Treatment Experienced patients
Human Immunodeficiency Virus (HIV)
Active, not recruiting
13+

To find a center near you, please provide a Country or Postal Code.

208948-Safety of Lamivudine (3TC) in subjects with renal impairment
208948-Safety of Lamivudine (3TC) in subjects with renal impairment
Human Immunodeficiency Virus (HIV)
Recruiting

No Limit

To find a center near you, please provide a Country or Postal Code.

212305-Juluca® drug use-results survey
212305-Juluca® drug use-results survey
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

111762-A Study of GSK1349572 versus Raltegravir (RAL) with Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
111762-A Study of GSK1349572 versus Raltegravir (RAL) with Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

201585-Study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current antiretroviral regimen in virologically suppressed HIV-1-infected adults
201585-Study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current antiretroviral regimen in virologically suppressed HIV-1-infected adults
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

117172-A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in human immunodeficiency virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
117172-A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in human immunodeficiency virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)